Scientists urge US Congress to reconsider bill that could allow genes to be patented
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l4252 (Published 17 June 2019) Cite this as: BMJ 2019;365:l4252- Owen Dyer
- Montreal
Nine Nobel prize winners are among 83 leading scientists and physicians who have written to US legislators urging them not to rush through changes to patent law that could lead to the patenting of genes—and even of laws of nature.1
The scientists’ letter echoes concerns expressed in a previous letter sent to Congress two weeks ago from 170 organisations, including many US scientific and clinical societies.2
Both groups are alarmed by proposed changes that would rewrite section 101 of the Patent Act. The purpose of that clause is to prevent abuse of the patent process by people who …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.